ANYTIMEkANYPLACEkANYWHERE - Heinz
ANYTIMEkANYPLACEkANYWHERE - Heinz
ANYTIMEkANYPLACEkANYWHERE - Heinz
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The weighted-average discount rate used in the calculation of the accumulated postretirement<br />
benefit obligation and the net postretirement benefit cost was 7.7% in 2000, 6.9% in 1999<br />
and 1998. The assumed annual composite rate of increase in the per capita cost of companyprovided<br />
health care benefits begins at 7.2% for 2000, gradually decreases to 5.3% by 2007,<br />
and remains at that level thereafter. Assumed health care cost trend rates have a significant<br />
effect on the amounts reported for postretirement medical benefits. A one-percentage-point<br />
change in assumed health care cost trend rates would have the following effects:<br />
1% Increase 1% Decrease<br />
Effect on total service and interest cost components $ 1,537 $ (1,349)<br />
Effect on postretirement benefit obligation 15,860 (13,988)<br />
12. FINANCIAL<br />
INSTRUMENTS<br />
Interest Rate Swap Agreements: As of May 3, 2000, the company was party to an interest rate<br />
swap with a notional amount of £50 million and a settlement date of April 2001. The swap<br />
converts a 6.25% fixed rate exposure, on long-term debt maturing in 2030, to a floating rate<br />
exposure. As of April 28, 1999, no such agreements were outstanding.<br />
Foreign Currency Contracts: As of May 3, 2000 and April 28, 1999, the company held currency<br />
swap contracts with an aggregate notional amount of approximately $90 million and<br />
$110 million, respectively. As of May 3, 2000, these contracts mature in 2002. The company<br />
held separate contracts to purchase certain foreign currencies as of May 3, 2000 and April 28,<br />
1999 totaling approximately $490 million and $510 million, respectively, which mature within<br />
one year of the respective fiscal year-end. The company also held separate contracts to sell<br />
certain foreign currencies as of May 3, 2000 and April 28, 1999 of approximately $105 million<br />
and $390 million, respectively. As of May 3, 2000, these contracts mature in 2001 and 2002.<br />
Net unrealized gains and losses associated with the company’s foreign currency contracts as<br />
of May 3, 2000 and April 28, 1999 were not material.<br />
Commodity Contracts: As of May 3, 2000 and April 28, 1999, the notional values and unrealized<br />
gains or losses related to commodity contracts held by the company were not material.<br />
Fair Value of Financial Instruments: The company’s significant financial instruments include<br />
cash and cash equivalents, short- and long-term investments, short- and long-term debt,<br />
currency exchange agreements, interest rate swaps and guarantees.<br />
In evaluating the fair value of significant financial instruments, the company generally<br />
uses quoted market prices of the same or similar instruments or calculates an estimated fair<br />
value on a discounted cash flow basis using the rates available for instruments with the<br />
same remaining maturities. As of May 3, 2000 and April 28, 1999, the fair value of financial<br />
instruments held by the company approximated the recorded value.<br />
Concentrations of Credit Risk: Counterparties to currency exchange and interest rate derivatives<br />
consist of large major international financial institutions. The company continually monitors<br />
its positions and the credit ratings of the counterparties involved and, by policy, limits the<br />
amount of credit exposure to any one party. While the company may be exposed to potential<br />
losses due to the credit risk of non-performance by these counterparties, losses are not<br />
anticipated. Concentrations of credit risk with respect to accounts receivable are limited due<br />
to the large number of customers, generally short payment terms, and their dispersion across<br />
geographic areas.<br />
(66)